This piece from the National Public Radio discusses the importance of making routine HIV tests more accessible as part of the effort to reach the U.N.’s ambitious goal to eliminate HIV transmission by the year 2030.
It highlights the role of MedAccess and CHAI in supporting Hologic’s affordable testing initiative. It notes that the Hologic platform provides one of the most accurate ways to measure if a patient is responding to anti-retroviral drugs, with the added benefit of also being able to test for hepatitis B and C, as well as HPV.
The article cautions that whilst viral load testing plays a critical role in tackling the HIV epidemic, it will only work where laboratory infrastructure and health system delivery are up to the mark.
Read: NPR’S ARTICLE
Gavi, MedAccess and GlaxoSmithKline join forces to guarantee continued production of the RTS,S antigen for the RTS,S/AS01e malaria vaccine ahead of key policy and funding decisions.
MedAccess CEO Michael Anderson joined Laura Frigenti and Simba Makoni to discuss trends in financing for global health and how the COVID-19 pandemic has affected funding.
Extension will support UNICEF's work to accelerate access to essential supplies for countries around the world